Concord Drugs standalone Dec '15 sales at Rs 13.37 crore
Concord Drugs has reported a sales total income from operations of Rs 13.37 crore and a net profit of Rs 1.87 crore for the quarter ended Dec '15
February 22, 2016 / 10:04 IST
| Concord Drugs has reported a standalone total income from operations of Rs 13.37 crore and a net profit of Rs 1.87 crore for the quarter ended Dec '15. Other income for the quarter was Rs 0.11 crore. | | For the quarter ended Dec 2014 the standalone total income from operations was Rs 10.11 crore and net profit was Rs 0.18 crore, and other income Rs 0.03 crore. | | Concord Drugs shares closed at 42.25 on February 19, 2016 (BSE) and has given -28.99% returns over the last 6 months and 111.36% over the last 12 months. |
|
| | Concord Drugs | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '15 | Sep '15 | | | Dec '14 | | Net Sales/Income from operations | 13.27 | 11.89 | | | 10.08 | | Other Operating Income | 0.11 | 0.06 | | | 0.03 | | Total Income From Operations | 13.37 | 11.95 | | | 10.11 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | -- | -- | | | -- | | Purchase of Traded Goods | 8.80 | 9.44 | | | 7.80 | | Increase/Decrease in Stocks | -0.71 | 0.23 | | | -0.04 | | Power & Fuel | -- | -- | | | 0.13 | | Employees Cost | 0.26 | 0.26 | | | 0.14 | | Depreciation | 0.77 | 0.76 | | | 0.67 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 0.82 | 0.29 | | | 0.54 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 3.43 | 0.97 | | | 0.86 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | 3.43 | 0.97 | | | 0.86 | | Interest | 0.76 | 0.62 | | | 0.64 | | P/L Before Exceptional Items & Tax | 2.67 | 0.35 | | | 0.22 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | 2.67 | 0.35 | | | 0.22 | | Tax | 0.80 | 0.11 | | | 0.04 | | P/L After Tax from Ordinary Activities | 1.87 | 0.25 | | | 0.18 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 1.87 | 0.25 | | | 0.18 | | Equity Share Capital | 7.24 | 7.24 | | | 7.24 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 2.58 | 0.34 | | | 0.18 | | Diluted EPS | 2.58 | 0.34 | | | 0.18 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 2.58 | 0.34 | | | 0.18 | | Diluted EPS | 2.58 | 0.34 | | | 0.18 | | Public Share Holding | | | | | | | No Of Shares (Crores) | -- | 0.44 | | | 0.44 | | Share Holding (%) | -- | 60.79 | | | 60.79 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | -- | | | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | | | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | | | -- | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | -- | 0.28 | | | 0.28 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | 100.00 | | | 100.00 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | 39.21 | | | 39.21 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
